Stuart Fischer, MD, FACC, FACP, FSCAI

Dr. Stuart FischerDr. Stuart Fischer joined Los Alamitos Cardiovascular in 1985 and is co-founder of the medical practice.

"Patients, not the doctors, are the most important part of our practice. We strive to give the best care and advice, so our patients can always make informed decisions regarding their care..."

On Medicine
Medicine is in a constant state of change. Government regulations, insurance providers are only some of the difficulties with Medicine today. One constant in all of this turmoil, is Los Alamitos Cardiovascular's continued commitment to our patient's care.

On Los Alamitos Cardiovascular
We are 6 unique cardiologists who have come together to form a cohesive group, able to provide excellent, comprehensive cardiovascular and endovascular care for our patients.

On My Specialty
Cardiovascular and Endovascular care has seen tremendous growth, and staying ahead of the curve in order to provide state of the art care for our patients is our mission.

Dr. Stuart Fischer's Curriculum Vitae

Printable VersionView Printable CV
Specialty: Cardiovascular and Endovascular Diseases
Medical Education:
  • Cardiology Fellow, 1983 - 1985
    Division of Cardiology
    University of California, Irvine
    Orange, California
    Walter L. Henry, M.D., Chief
  • Medical Resident, 1980 - 1982
    Department of Internal Medicine
    University of Cincinnati Medical Center
    Cincinnati, Ohio
    Martin Goldberg, M.D., Chair
  • Straight Medical Intern, 1979 - 1980
    Department of Internal Medicine
    University of Cincinnati Medical Center
    Cincinnati, Ohio
    Martin Goldberg, M.D., Chair
  • Cornell University Medical College, 1977 - 1979
    New York, New York
  • Universita di Sassari, 1973 - 1977
    Faculta di Medicinav
    Sassari, Italy
  • Brooklyn College, 1969 - 1973
    Brooklyn, New York
    B.S. Biology
Positions:
  • Los Alamitos Cardiovascular, August 1985 - Present
    Cardiologist
  • Emergency Medicine, 1982 - 1983 (Full Time)
    St. Francis - St. George Hospital
    (Fischer Mangold Group)
    Cincinnati, Ohio
  • Medical Health Service, 1980 - 1983 (Part Time)
    (Staffing Three Cincinnati ER's)
  • Critical Care Physician,1981 - 1983 (Part Time)
    Bethesda Hospital
    Cincinnati, Ohio

University Appointments:

  • Assistant Clinical Professor of Medicine, University of California, Irvine, July 1989-present
  • Co-Director Interventional Fellowship Program, University of California Irvine-Long Beach Memorial Hospital, July 2000-present
Hospital Affiliations:
  • Long Beach Memorial Medical Center - Active Staff, December 1991
  • Founding Fellow, Memorial Heart Institute, January 1987
  • Los Alamitos Medical Center - Active Staff, April  1987 
  • University of California, Irvine - Courtesy Staff, April 1986
  • Lakewood Regional Medical Center - Active Staff, June 1990
Hospital Appointments:

Los Alamitos Medical Center

  • Chairman, Critical Care Committee 1989
  • Chairman, Department of Medicine 1990-1992
  • Member, Executive Committee 1989-Present
  • Director Cardiac Catheterization Lab 1989-Present
  • Director, Pacemaker Clinic 1985-Present
  • Director, Echocardiography Lab 1985-1997
  • Secretary-Treasurer Medical Staff 1992
  • Chairman, Quality Assurance Committee 1993
  • Vice Chief of Staff 1993
  • Chief of Staff 1994-1995
  • Member, Governing Board 1994-2001, 2004-Present
  • Chairman, Credentials Committee 1996-Present

Lakewood Regional Medical Center

  • Member, Executive Committee 2000-2001, 2004-2007
  • Director, Cardiac Catheterization Lab 2002-2005

Long Beach Memorial Medical Center

  • Member Interventional Cardiology Sub-Committee 1997-Present
  • Member Cardiology Credentials and QA Committee 1996-Present
Medical Licenses: Ohio - 44968
New York - 149958
California - G47229
Board Certifications:
  • American Board of Internal Medicine: Internal Medicine, 1982
  • American Board of Internal Medicine: Cardiovascular Diseases, 1985
  • American Board of Internal Medicine: Interventional Cardiology, 1999-2009 | 2011-2021
  • International Board of Heart Rhythm Examiners (IBHRE)
    Certification Examination for Competency in Cardiac Rhythm Device Therapy for the Physician 1988.(Certified Cardiac Device Specialist (CCDS)
Professional Societies:
  • American College of Cardiology, Fellow (F.A.C.C.)
  • American College of Physicians, Fellow (F.A.C.P.)
  • American Heart Association - Governing Board Long Beach Chapter
  • Los Angeles County Medical Association
  • American Medical Association American Society of Echocardiography
  • Los Angeles Echocardiography Society
  • Los Angeles Society of Interventional Cardiology
  • Heart Rhythm Society-IBHRE CCDS
  • The Society for Cardiac Angiography and Interventions, Fellow (F.S.C.A.I.)
  • The Society of Geriatric Cardiology, Fellow (F.S.G.C.)
Local Organizations: Rotary 1986-1989
Awards:
  • Sarah Lipson Seigal Memorial Award for Research, 1973
  • American Medical Association Physician’s Recognition Award in Continuing Medical Education, January 2008-January 2011
Clinical Expertise:

Non-Invasive Cardiology:
Echocardiography- TEE, Dobutamine and Stress Echo.

Invasive-Interventional Cardiovascular and Endovascular Diseases:
Catheterization, PTCA, Athrectomy, Stents, Laser Atherectomy, VBT, Pacing, Peripheral Vascular Disease, Peripheral Interventions, and Current Level II certification for performing and interpreting MDCTA.

Research Interests:
  • Echocardiographic Assessment of Mitral Stenosis, Two-Dimensional Echocardiography versus Doppler Pressure Half Time
    Exercise Echocardiography in Coronary Artery Disease
    Doppler Mitral Flow in Various Pathologic States
    Thin-Line Bi-Polar Pacemaker Leads, Intermedics

  • A Phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (ACS).
    Sponsor: F.Hoffmann-La Roche Ltd. Hoffmann-La Roche, Inc. Roche Global Development

  • A Multi-center, Randomized, Controlled Study to Investigate the Safety and Tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Iron Dextran in treating Iron Deficiency Anemia in Subjects Who Are Not Dialysis Dependent.
    Sponsor: Luitpold Pharmaceuticals, Inc.

  • A Phase3, randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176B Versus Warfarin in Subjects with Atrial Fibrillation -  Effective aNticoaGulation with xA next Generation in Aterial Fibrillation. (ENGAGE-AF)
    Sponsor: Daiichi Sankyo Pharma Development

  • Freedom - A Frequent Optimization Study the Quick Opt ™ Method.
    Sponsor: St Jude

  • Registry of AT/AF Episodes in the CRM Device Population: Rate Registry.
    Sponsor: St. Jude

  • PA 32540-302: A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers.
    Sponsor POZEN Inc.

Publications:
  • Dabestani A, Takenaka K, Allen B, Gardin J, Fischer S, Russell D, Henry W, Effects of Spontaneous Respiration on Diastolic Left Ventricular Filling Assessed by Pulsed Doppler Echocardiography.  Am J Cardiol 1988; 61:1356-1358.

  • Kumar P, Agarwal P, VanNatta B, Shandling A, Fischer S, McAtee P, Messenger J, Clinical evaluation of ThinLine II (models 430-25 and 438-25 Intermedics) bipolar pacing leads. PACE 1999; 22 Part II 869.